Carregant...
Targeting Specific Cells in the Brain with Nanomedicines for CNS Therapies
Treatment of Central Nervous System (CNS) disorders still remains a major clinical challenge. The Blood-brain-barrier (BBB), known as the major hindrance, greatly limits therapeutics penetration into the brain. Moreover, even though some therapeutics can cross BBB based on their intrinsic properties...
Guardat en:
| Publicat a: | J Control Release |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4903089/ https://ncbi.nlm.nih.gov/pubmed/26686078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.12.013 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|